Humana (NYSE:HUM) Upgraded at Bank of America

Bank of America upgraded shares of Humana (NYSE:HUM) from an underperform rating to a neutral rating in a report released on Wednesday, Marketbeat Ratings reports. They currently have $308.00 price target on the insurance provider’s stock, up from their prior price target of $247.00.

Several other equities analysts have also issued reports on the stock. Wells Fargo & Company cut their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price for the company in a report on Tuesday, October 8th. TD Cowen raised their price target on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Truist Financial decreased their target price on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research report on Friday, October 11th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $315.86.

Humana Trading Up 0.1 %

NYSE:HUM traded up $0.36 during mid-day trading on Wednesday, hitting $288.12. 1,691,681 shares of the stock traded hands, compared to its average volume of 2,587,340. Humana has a 52 week low of $213.31 and a 52 week high of $527.18. The firm’s 50 day moving average is $289.38 and its two-hundred day moving average is $332.67. The stock has a market capitalization of $34.69 billion, a price-to-earnings ratio of 25.53, a PEG ratio of 2.28 and a beta of 0.52. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, equities research analysts predict that Humana will post 15.83 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.23%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.

Institutional Trading of Humana

Several institutional investors have recently bought and sold shares of HUM. Mendota Financial Group LLC boosted its holdings in Humana by 9.2% in the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after buying an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC raised its stake in Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after purchasing an additional 31 shares during the last quarter. CarsonAllaria Wealth Management Ltd. lifted its holdings in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Moors & Cabot Inc. boosted its stake in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after purchasing an additional 40 shares during the last quarter. Finally, Harbour Investments Inc. grew its holdings in shares of Humana by 10.5% during the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after buying an additional 41 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.